Minerva Neurosciences Valuation
| NERV Stock | USD 2.52 0.01 0.40% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Minerva Neurosciences secures a last-minute Real Value of $4.61 per share. The latest price of the firm is $2.52. Our model forecasts the value of Minerva Neurosciences from analyzing the firm fundamentals such as Return On Equity of -6.75, current valuation of 58.8 M, and Shares Owned By Insiders of 22.26 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend buying undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Undervalued
Today
Please note that Minerva Neurosciences' price fluctuation is very risky at this time. Calculation of the real value of Minerva Neurosciences is based on 3 months time horizon. Increasing Minerva Neurosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Minerva Neurosciences is useful when determining the fair value of the Minerva stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Minerva Neurosciences. Since Minerva Neurosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Minerva Stock. However, Minerva Neurosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.52 | Real 4.61 | Hype 2.53 | Naive 3.16 |
The real value of Minerva Stock, also known as its intrinsic value, is the underlying worth of Minerva Neurosciences Company, which is reflected in its stock price. It is based on Minerva Neurosciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Minerva Neurosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Minerva Neurosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Minerva Neurosciences helps investors to forecast how Minerva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Minerva Neurosciences more accurately as focusing exclusively on Minerva Neurosciences' fundamentals will not take into account other important factors: Minerva Neurosciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Minerva Neurosciences's current stock value. Our valuation model uses many indicators to compare Minerva Neurosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Minerva Neurosciences competition to find correlations between indicators driving Minerva Neurosciences's intrinsic value. More Info.Minerva Neurosciences is considered to be number one stock in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 0.04 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Minerva Neurosciences is roughly 25.98 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Minerva Neurosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Minerva Neurosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Minerva Neurosciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Minerva Neurosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Minerva Neurosciences and how it compares across the competition.
About Minerva Neurosciences Valuation
The stock valuation mechanism determines the current worth of Minerva Neurosciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Minerva Neurosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Minerva Neurosciences based exclusively on its fundamental and basic technical indicators. By analyzing Minerva Neurosciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Minerva Neurosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Minerva Neurosciences. We calculate exposure to Minerva Neurosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Minerva Neurosciences's related companies.Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. Minerva Neuroscie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.
8 Steps to conduct Minerva Neurosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Minerva Neurosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Minerva Neurosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Minerva Neurosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Minerva Neurosciences' revenue streams: Identify Minerva Neurosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Minerva Neurosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Minerva Neurosciences' growth potential: Evaluate Minerva Neurosciences' management, business model, and growth potential.
- Determine Minerva Neurosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Minerva Neurosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Minerva Neurosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Minerva Neurosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 6.5 M | |
| Forward Price Earnings | 11.2108 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.